Stock ANNX ANNEXON, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Annexon, Inc.

Equities

ANNX

US03589W1027

Market Closed - Nasdaq
Other stock markets
 01:30:00 03/05/2024 am IST 		5-day change 1st Jan Change
4.66 USD -1.79% Intraday chart for Annexon, Inc. +1.53% +2.64%
01/04 JPMorgan Raises Price Target on Annexon to $13 From $11, Maintains Overweight Rating MT
27/03 Wells Fargo Adjusts Price Target on Annexon to $12 From $11, Maintains Overweight Rating MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting
GL
Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting
AQ
ANNEXON REPORTS INDUCEMENT GRANTS TO NEW EMPLOYEES UNDER NASDAQ LISTING RULE 5635(4)
AQ
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
GL
Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
GL
Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
AQ
JPMorgan Raises Price Target on Annexon to $13 From $11, Maintains Overweight Rating
MT
Wells Fargo Adjusts Price Target on Annexon to $12 From $11, Maintains Overweight Rating
MT
Annexon Q4 Loss Narrows
MT
Annexon, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Annexon Reports Fourth Quarter and Year-End 2023 Financial Results and Key Anticipated Milestones
GL
Annexon, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
North American Morning Briefing : Stocks Struggle After New Records
DJ
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
GL
North American Morning Briefing : Inflation Worries Continue to Weigh on Mood
DJ
North American Morning Briefing : Stock Futures -2-
DJ
Transcript : Annexon, Inc. - Special Call
JPMorgan Upgrades Annexon to Overweight From Neutral, Price Target is $11
MT
Annexon Biosciences to Present at the TD Cowen 44th Annual Health Care Conference
GL
Annexon Biosciences to Present at the TD Cowen 44th Annual Health Care Conference
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ANNX Stock
  4. News Annexon, Inc.